146 related articles for article (PubMed ID: 16368125)
1. gC1qR expression in chimpanzees with resolved and chronic infection: potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection.
Yao ZQ; Shata MT; Tricoche N; Shan MM; Brotman B; Pfahler W; Hahn YS; Prince AM
Virology; 2006 Mar; 346(2):324-37. PubMed ID: 16368125
[TBL] [Abstract][Full Text] [Related]
2. HCV-specific T-cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance.
Ruys TA; Nanlohy NM; van den Berg CH; Hassink E; Beld M; van de Laar T; Bruisten S; Wit F; Krol A; Prins M; Lange J; van Baarle D
J Viral Hepat; 2008 Jun; 15(6):409-20. PubMed ID: 18221302
[TBL] [Abstract][Full Text] [Related]
3. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.
Forns X; Payette PJ; Ma X; Satterfield W; Eder G; Mushahwar IK; Govindarajan S; Davis HL; Emerson SU; Purcell RH; Bukh J
Hepatology; 2000 Sep; 32(3):618-25. PubMed ID: 10960458
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus: immunosuppression by complement regulatory pathway.
Yao ZQ; Ray S; Eisen-Vandervelde A; Waggoner S; Hahn YS
Viral Immunol; 2001; 14(4):277-95. PubMed ID: 11792059
[TBL] [Abstract][Full Text] [Related]
5. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection.
Sugimoto K; Ikeda F; Stadanlick J; Nunes FA; Alter HJ; Chang KM
Hepatology; 2003 Dec; 38(6):1437-48. PubMed ID: 14647055
[TBL] [Abstract][Full Text] [Related]
6. Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence.
Large MK; Kittlesen DJ; Hahn YS
J Immunol; 1999 Jan; 162(2):931-8. PubMed ID: 9916717
[TBL] [Abstract][Full Text] [Related]
7. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation.
Kittlesen DJ; Chianese-Bullock KA; Yao ZQ; Braciale TJ; Hahn YS
J Clin Invest; 2000 Nov; 106(10):1239-49. PubMed ID: 11086025
[TBL] [Abstract][Full Text] [Related]
8. T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling.
Yao ZQ; King E; Prayther D; Yin D; Moorman J
Viral Immunol; 2007; 20(2):276-87. PubMed ID: 17603844
[TBL] [Abstract][Full Text] [Related]
9. Protection against chronic hepatitis C virus infection after rechallenge with homologous, but not heterologous, genotypes in a chimpanzee model.
Prince AM; Brotman B; Lee DH; Pfahler W; Tricoche N; Andrus L; Shata MT
J Infect Dis; 2005 Nov; 192(10):1701-9. PubMed ID: 16235167
[TBL] [Abstract][Full Text] [Related]
10. The core-specific precursor T cell response is directed to the N-terminal and central parts of the protein and positively correlates to the viral load in chronically HCV-infected patients.
Janvier G; Chaix ML; Fontaine H; Bresson JL; Pol S; Riviere Y
Virology; 2005 Sep; 340(2):318-25. PubMed ID: 16054187
[TBL] [Abstract][Full Text] [Related]
11. The molecular basis of HCV-mediated immune dysregulation.
Eisen-Vandervelde AL; Yao ZQ; Hahn YS
Clin Immunol; 2004 Apr; 111(1):16-21. PubMed ID: 15093547
[TBL] [Abstract][Full Text] [Related]
12. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
[TBL] [Abstract][Full Text] [Related]
13. Interaction between the hepatitis C virus and the immune system.
Rehermann B
Semin Liver Dis; 2000; 20(2):127-41. PubMed ID: 10946419
[TBL] [Abstract][Full Text] [Related]
14. A hepatitis C virus (HCV) core protein derived peptide inhibits HCV specific lymphocyte proliferation.
Langhans B; Lechmann M; Ihlenfeldt H; Jung G; Giers G; Schweitzer S; El Bakri M; Sauerbruch T; Spengler U
Eur J Med Res; 2000 Mar; 5(3):115-20. PubMed ID: 10756165
[TBL] [Abstract][Full Text] [Related]
15. Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection.
Bassett SE; Guerra B; Brasky K; Miskovsky E; Houghton M; Klimpel GR; Lanford RE
Hepatology; 2001 Jun; 33(6):1479-87. PubMed ID: 11391537
[TBL] [Abstract][Full Text] [Related]
16. A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.
Folgori A; Capone S; Ruggeri L; Meola A; Sporeno E; Ercole BB; Pezzanera M; Tafi R; Arcuri M; Fattori E; Lahm A; Luzzago A; Vitelli A; Colloca S; Cortese R; Nicosia A
Nat Med; 2006 Feb; 12(2):190-7. PubMed ID: 16462801
[TBL] [Abstract][Full Text] [Related]
17. Effects of iron loading on pathogenicity in hepatitis C virus-infected chimpanzees.
Bassett SE; Di Bisceglie AM; Bacon BR; Sharp RM; Govindarajan S; Hubbard GB; Brasky KM; Lanford RE
Hepatology; 1999 Jun; 29(6):1884-92. PubMed ID: 10347134
[TBL] [Abstract][Full Text] [Related]
18. A critical role for the chimpanzee model in the study of hepatitis C.
Bukh J
Hepatology; 2004 Jun; 39(6):1469-75. PubMed ID: 15185284
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees.
Shata MT; Anthony DD; Carlson NL; Andrus L; Brotman B; Tricoche N; McCormack P; Prince A
J Viral Hepat; 2002 Nov; 9(6):400-10. PubMed ID: 12431201
[TBL] [Abstract][Full Text] [Related]
20. Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance.
Folgori A; Spada E; Pezzanera M; Ruggeri L; Mele A; Garbuglia AR; Perrone MP; Del Porto P; Piccolella E; Cortese R; Nicosia A; Vitelli A;
Gut; 2006 Jul; 55(7):1012-9. PubMed ID: 16484505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
